Clinical Microbiology
Clinical microbiology is the area of laboratory medicine concerned with detecting, identifying, and characterising the microorganisms that cause human infection - bacteria, fungi, viruses, mycobacteria, and parasites - and with predicting how those organisms will respond to antimicrobial agents. It links the patient specimen to actionable laboratory information through culture, microscopy, immunoassay, molecular amplification, and mass spectrometry.
Definition
Clinical microbiology is the laboratory discipline that establishes the microbial cause of infection in a patient specimen and characterises the causative organism - including its identity and its antimicrobial susceptibility - to support diagnosis and surveillance.
Scope
The area covers the workflow of the diagnostic microbiology laboratory: specimen collection and quality, primary isolation and microscopy, phenotypic and genotypic organism identification, susceptibility and resistance testing, and the serologic and molecular detection of pathogens that are difficult or impossible to culture. It is organised here into topic entries for bacterial identification, antimicrobial susceptibility testing, fungal identification and antifungal testing, viral detection and serology, and mycobacterial identification and resistance. The entry treats these as laboratory-science methods, not as clinical management instructions.
Sub-topics
Core questions
- Which microorganism, if any, is present in this specimen, and is it a pathogen or contaminant?
- What method - culture, microscopy, antigen detection, serology, nucleic-acid amplification, or mass spectrometry - best detects and identifies it?
- Is the organism susceptible or resistant to the antimicrobial agents that might be used against it?
- How are the analytical performance, turnaround time, and clinical interpretation of a microbiology test established and limited?
Key concepts
- Specimen quality and pre-analytical variables
- Culture-based isolation versus culture-independent detection
- Phenotypic identification (growth, biochemistry, morphology)
- Genotypic and proteomic identification (sequencing, MALDI-TOF mass spectrometry)
- Antimicrobial susceptibility and resistance testing
- Serology (antibody and antigen detection)
- Nucleic-acid amplification testing
- Analytical sensitivity, specificity, and turnaround time
- Colonisation versus infection
Mechanisms
Diagnostic microbiology proceeds from a specimen to a result through a sequence of analytical steps. Microscopy and primary culture isolate or visualise organisms; phenotypic tests then read growth characteristics and biochemical reactions, while proteomic identification by MALDI-TOF mass spectrometry reads each organism's protein mass spectrum against a reference database, which reshaped routine identification workflows (Clark et al., 2013). Where organisms are slow-growing or non-cultivable, the laboratory turns to immunoassay-based antigen or antibody detection and to nucleic-acid amplification such as real-time PCR, which detects pathogen genomes directly in the specimen (Espy et al., 2006). Susceptibility testing then exposes an isolate to defined antimicrobial concentrations and reads inhibition of growth (Jorgensen & Ferraro, 2009). Across these methods, the laboratory must distinguish true infection from colonisation or contamination and balance analytical sensitivity, specificity, and turnaround time (Caliendo et al., 2013).
Clinical relevance
Clinical microbiology generates much of the evidence on which the recognition and surveillance of infectious disease rests, and its outputs - an organism identification and a susceptibility profile - inform clinical reasoning about infection. The entries here describe how that laboratory evidence is produced and interpreted; they are a reference to method and concept and are not a basis for individual diagnostic or treatment decisions, which depend on the full clinical context.
Epidemiology
The clinical microbiology laboratory is also a sentinel for population health: its identifications and susceptibility data feed antimicrobial-resistance surveillance and outbreak detection. Faster and more accurate diagnostics have been argued to be a public-health priority precisely because they shape both individual care and the monitoring of emerging resistance (Caliendo et al., 2013).
History
Diagnostic microbiology grew from the culture and staining methods of the late nineteenth century into a laboratory discipline that progressively added immunoassays, automated phenotypic systems, nucleic-acid amplification, and, more recently, MALDI-TOF mass spectrometry and genomic methods. The adoption of mass spectrometry for routine identification (Clark et al., 2013) and the expansion of molecular testing (Espy et al., 2006; Caliendo et al., 2013) mark the most recent shifts in how laboratories establish a microbial diagnosis.
Related topics
Seminal works
- clark-2013
- espy-2006
- jorgensen-2009
- caliendo-2013
Frequently asked questions
- How is clinical microbiology different from microbiology in general?
- General microbiology studies microorganisms broadly; clinical microbiology is the laboratory-medicine application that detects and characterises the microorganisms causing human infection in patient specimens, including their antimicrobial susceptibility.
- Why does a microbiology laboratory use several different methods?
- No single method detects every pathogen. Culture, microscopy, antigen and antibody detection, nucleic-acid amplification, and mass spectrometry each suit different organisms and questions, so laboratories combine them according to the specimen and the suspected pathogen.